Drug Information Association Logo

The Impact of Regulatory Reform in Mexico on Pharmaceutical Product Approval Rates

Time

Wed, Jun 18 7:15AM
W 12

Title

The Impact of Regulatory Reform in Mexico on Pharmaceutical Product Approval Rates

Abstract Summary

We compiled and analyzed product approval records from Mexico’s regulatory authority (COFEPRIS) for the years 2001-2013. Metrics of interest included product approvals per year, total number of manufacturers obtaining at least 1 approval, and central tendency values for approvals per firm.

Poster Presenter

Raul M. Vinueza
Project Manager,
Data-Pharma LLC
United States